Haan, “prolol” group se aapka matlab usually beta-blockers hota hai, jaise propranolol, metoprolol, atenolol, bisoprolol. Type 2 diabetes mein ye har patient ke liye mana nahi hote, lekin savdhani zaroor chahiye.
Propranolol, jo non-selective beta-blocker hai, mein khas concern hota hai:
- Ye low sugar (hypoglycemia) ka common warning sign, especially dhak-dhak/tez pulse, chhupa sakta hai.
- Kabhi low sugar ko lamba ya severe bana sakta hai, khaaskar agar insulin ya sulfonylurea tablets, jaise glimepiride/gliclazide, chal rahi hon.
- Blood sugar pattern par kuch asar ho sakta hai, isliye monitoring zaroori hai.
Agar beta-blocker heart attack, angina, heart failure, arrhythmia, ya kisi aur strong reason ke liye diya gaya hai, to diabetes ke bawajood doctor use rakh sakte hain. Diabetes aur asthma/PVD mein relatively beta-1 selective options, jaise metoprolol ya bisoprolol, kabhi better choice ho sakte hain, though these too need monitoring. Katzung notes that beta-1 selectivity can be advantageous in patients with diabetes. - Katzung's Basic and Clinical Pharmacology, 16th Edition, p. 3456
Kya karein:
- Dawa apne aap band na karein, especially propranolol ko suddenly stop karna risky ho sakta hai.
- Sugar regularly check karein, aur low sugar ke dusre signs pe dhyan dein: pasina, kampan, bhook, confusion, chakkar, unusual weakness.
- Agar baar-baar low sugar, sugar control kharab, wheezing/asthma, ya bahut slow pulse ho, prescribing doctor se medicine review karwayein.
Mayo Clinic guidance also warns that propranolol can alter glucose levels and mask signs of hypoglycemia.